Lisovska V. S., Nedopytanska N. M., Reshavska O. V., Bagliy Y. A.


About the author:

Lisovska V. S., Nedopytanska N. M., Reshavska O. V., Bagliy Y. A.



Type of article:

Scentific article


Objective. Carbendazim is one of the widely used benzimidazole fungicides. It mechanism of action is to inhibit polymerization of microtubules of the mitotic spindle in fungal cells and damage the cell division. A similar effect on mammalian and human cells is not ruled out. Well known reproductive and developmental toxicity of carbendazime, but the question of its carcinogenicity has not yet been clarified. Carbendazim cause liver tumours in mice and classified by EPA (1989) as “possible human carcinogen” and not classified in one of the carcinogenicity categories in EC. In Ukraine are 27 registered fungicides containing the active ingredient carbendazim, mainly generic, so the question of its carcinogenicity is still relevant. Object and methods. In our study, the carcinogenic effect of carbendazim technical 98 % were investigated by chronic 24-month experiment in Wistar rats. Male and female rats aged between 1.5 and 2.0 months were assigned randomly to experimental and control groups, each group consisted of 70 rats of each sex. Rats receiving carbendazim at a dose of 5, 25, or 75 mg/kg body weight by gavage. All rats were observed daily for general physical condition and weekly were recorded body weights and the palpable neoplasms. Died and sacrificed (in according to study plan) animals have been necropsied and tissue samples were collected for histopathology. Statistically was evaluated such direct indicators of carcinogenic effect as the tumor rate, latent period and survival of animals with tumors. Results. According to the obtained results in our study, benign neoplasms prevailed among tumors in all groups and were usual occurring neoplasm, characteristic to Wistar rats. The incidence of malignant neoplasia across the treatment and control groups was similar. Treatment-related tumours included neoplasms of mammary gland, thyroid gland and pituitary in femals and testis tumours in male without clear dose dependence. There was low but significant increased tumours of thyroid gland in the 5 mg/kg female group, mammary gland in the 5 and 25 mg/kg groups, pituitary in the 75 mg/kg and leydig cells tumours in the 25 mg/kg male group. Thus, the most frequently tumors were in the organs of the endocrine and reproductive system. The tumor rate of this localization in males was 9 %, 12 %, 6 % in minimal, middle and high dose opposite 5 % in the control, and in females – 21 %, 19 %, 18 % and 10 %, respectively. Conclusion. Under the conditions of 2-year studies, there was evidence of carcinogenic activity of carbendazime in rats based on increased incidences of hormone-dependent tumors without clear dose dependence and reduction of their latent period. Thus, the obtained data indicate a weak carcinogenic effect of carbendazim, most likely, an epigenetic mechanism. Non-linear dose reactions have been clearly established for aneunogens, which also does not exclude the way the oncogenic effect is realized.


carbendazim, carcinogenesis, tumors, Wistar rats.


  1. Madia F, Worth A, Whelan M, Corvi R. Carcinogenicity assessment: Addressing the challenges of cancer and chemicals in the environment: Review article. Environment International. 2019;128:417-29. Available from:
  2. Kara M, Jannuzzi AT, Yön S. In-Vitro Investigation of the Cytotoxic and Genotoxic Effects of Benzimidazole Group Pesticides Benomyl and Carbendazim. J Toxicol Cur Res. 2019;3:007. DOI: 10.24966/TCR-3735/100007
  3. Vela-Corcía D, Romero D, de Vicente A, Pérez-García A. Analysis of β-tubulin-carbendazim interaction reveals that binding site for MBC fungicides does not include residues involved in fungicide resistance. Sci Rep. 2018;8:7161. DOI: 10.1038/s41598-018-25336-5. Available from:
  4. Conclusion on the peer review of the pesticide risk assessment of the active substance carbendazim. European Food Safety Authority (EFSA), Parma, Italy. EFSA Journal. 2010;8(5):1598. Available from:
  5. Lu S-Y. Androgen Receptor Plays a Vital Role in Benomyl- or Carbendazim-Induced Reproductive and Developmental Toxicity and EndocrineDisrupting Activity in Rats. In book: Endocrine Disruptors. Editor Ahmed RG, IntechOpen. DOI: 10.5772/intechopen.78276. Available from:
  6. Sakr SA, Shalaby SY. Carbendazim-induced testicular damage and oxidative stress in albino rats: ameliorative effect of licorice aqueous extract. Toxicol Ind Health. 2014;30:259-67. Available from:
  7. Rama EM, Bortolan S, Vieira ML, Gerardin DC, Moreira EG. Reproductive and possible hormonal effects of carbendazim. Regulatory Toxicology and Pharmacology. 2014;69(3):476-86. DOI: 10.1016/j.yrtph.2014.05.016. Available from:
  8. Kolianchuk Y. Izuchenie gonado- i reproductivnoy toksichnosti karbendazima tehnicheskogo na samtsah i samkah krys Wistar Han. Ukrainskiy jurnal suchasnyh problem toxicologii. 2018;4(84):36-41. Dostupno: [in Russian].
  9. Zhou J, Xiong K, Yang Y, Ye X, Liu J, Li F. Deleterious effects of benomyl and carbendazim on human placental trophoblast cells. Reprod Toxicol. 2015;51:64-71. Available from:
  10. US Environmental Protection Agency Office of Pesticide Programs. Chemicals Evaluated for Carcinogenic Potential Annual Cancer Report 2018. 2018;40. Available from:
  11. Silva RC, Barros KA, Pavao AC. Carcinogenicity of carbendazim and its metabolites. Química Nova [Internet]. 2014;37(8):1329-34. Available from:
  12. Goyal K, Sharma A, Arya R, Sharma R, Gupta GK, Sharma AK. Double Edge Sword Behavior of Carbendazim: A Potent Fungicide With Anticancer Therapeutic Properties. Anticancer Agents Med Chem. 2018;18(1):38-45. DOI: 10.2174/1871520616666161221113623
  13. Kumar A, Banerjee S, Roy P, Sondhi SM, Sharma A. Solvent-free synthesis and anticancer activity evaluation of benzimidazole and perimidine derivatives. Mol Divers. 2018;22(1):113-27. DOI: 10.1007/s11030-017-9790-3
  14. Yenjerla M, Cox C, Wilson L, Jordan MA. Carbendazim inhibits cancer cell proliferation by suppressing microtubule dynamics. J Pharmacol Exp Ther. 2009;328(2):390-8. DOI: 10.1124/jpet.108.143537
  15. EU Pesticides database. Active substance carbendazime. Available from: public/?event=activesubstance.selection&language=EN
  16. List of banned pesticides and pesticides watchlist. Version 1.0 2015. Available from: 12/EN_ UTZ_ List-of-Banned-Pesticides Watchlist_v1.0_ 2015.pdf
  17. Perelik pestytsydiv i agrohimikativ, dozvolenyh do vykorystannia v Ukraini, ofitsiyne vydannia. Kyiv: Univest Media; 2018. 1040 s. [in Ukrainian].
  18. Lisovska VS, Nedopytanska NM, Reshavska ОV, Tereshchenko NV, Bagliy EА. Identifikatsia kantserogennosti karbendazimu: eksperimentalne doslidjennia na myshah linii СВА. Ukrainskiy jurnal suchasnyh problem toxicologii. 2019;3(87):18-23. [in Ukrainian].
  19. Pathology of tumours in laboratory animals. Tumors of the Rat. Second Edition. Edited by Turusov V. and Mohr U. IARC Scientific Publications. 1991;99:766.
  20. Plohinskiy NА. Biometria. Moskva: Izdatelstvo Moskovskogo gosudarstvennogo universiteta; 1970. 352 s. [in Russian].
  21. Turusov VS, Parfionov YD. Metody vyavlenia i reglamentirovania himicheskih kantserogenov. Moskva: Meditsina; 1986. 125 s. [in Russian].
  22. Peto R, Pike NE, Day NF, Gray RG, Lee PN, Parish S, et al. Guidelines for simple, sensitive significance tests for carcinogenic effects in longterm animal experiments. In IARC Monographs on the evaluation of carcinogenic risk of chemicals to human. 1980;2:311-426.
  23. Weber K. Differences in Types and Incidence of Neoplasms in Wistar Han and Sprague-Dawley Rats. Toxicologic Pathology. 2017;45(1):64-75. DOI: 10.1177/0192623316672075.
  24. Hojo M, Sakamoto Y, Maeno A, Tayama K, Tada Y, Yuzawa K, et al. A histopathological analysis of spontaneous neoplastic and non-neoplastic lesions in aged male RccHan: WIST rats. Technical Report. Journal of Toxicologic Pathology. 2020;33(1):47-55. DOI: 10.1293/tox.2019-0064
  25. Hernández LG, van Benthem J, Johnson GE. A Mode-of-Action Approach for the Identification of Genotoxic Carcinogens. PLoS ONE. 2013;8(5):e64532. Available from: journal.pone.0064532

Publication of the article:

«Bulletin of problems biology and medicine» Issue 1 (155), 2020 year, 321-328 pages, index UDK 616-006:632.95.024:59.08